-
Home
-
About Us
- Contact Us
- Board of Trustees
- Committees
- Special Interest Groups
- Early Careers Forum
- Awards and Prizes
- Volunteer with us
- Articles of Association, Regulation and Signed Accounts
- Website FAQs
- Work for us
-
News
- Blood stem cells diversify earlier than thought
- Backing for new treatment for chronic graft versus host disease
- Mutations study offers hope for myelodysplastic syndromes patients
- New blood platelet tool easier and more precise
- New hope of eradicating aggressive form of AML
- CD20-directed immunotherapy resistance partially explained
- Risk of blood clots falls rapidly after stopping hormonal contraceptives
- Common beta blocker to be trialled for sickle cell cardiomyopathy
- Prophylactic treatment may prevent myeloma immunotherapy side effects
- Age affects diagnosis of von Willebrand disease
- Gut bacteria combination could protect stem cell transplantation patients
- Key regulator of blood stem cell fate identified
- Individual risk prediction model for multiple myeloma unveiled
- Obesity linked to blood cancer precursor MGUS
- Young sickle cell patients less likely to have COVID-19 vaccines
- January 2024 Message from BSH President - Dr Josh Wright
- Hepatitis may trigger a treatable myeloma, researchers report
- NHS to offer blood group genotype test for transfusion patients
- Promising results for CAR-NK cells for B-cell cancers
- AI recognises mutations from AML bone marrow images
- Inherited genetic variants’ role in MPNs
- RNA sequencing 'promising' for B-ALL paediatric patients
- Children’s cancer taskforce launched
- Lipid-based classification of AML resistance risk
- Finding the best hypertension treatment for patients taking BTKi
- Genetic study of anticoagulant side-effects
- Hope for CRISPR technique for FHL
- New breakthrough in leukaemia-HIV double treatment case
- Call for action on ‘blood deserts’
- Hope for STAb-T cell therapy for myeloma
- Proteins identified that help lymphoma hide
- February 2024 Message from BSH President - Dr Josh Wright
- Designer antibody could boost AML treatment
- NHS approves new GvHD drug
- Skeleton clues to ancient anaemia prevalence
- Wide-ranging European guidance on adult ALL published
- Molecular profile of rare leukaemia revealed
- Hodgkin’s survivors omitted from high-risk breast checks
- AI shows lymphoma detection promise
- Cancer frequency among CAR-T adverse events
- Blood sample requests increase later willingness to donate stem cells
- Stem cell transplant outcomes improving among over 65s
- Blood production may vary across skeleton
- New SCID mutation identified
- March 2024 Message from BSH President - Dr Josh Wright
- Methylation profiling predicts myelodysplastic syndrome treatment response
- Changes that trigger aggressive follicular lymphoma identified
- Can some CLL patients live without specialist follow-up?
- Ancient ALL risk gene in Hispanic and Latino groups identified
- Familial Alzheimer’s disease transferred in mouse stem cell transplant
- TP53 mutations in AML increase CAR-T resistance
- Hope for overcoming AML treatment resistance
- Precision medicine improves care of relapsed paediatric cancers
- Synthetic platelets stop bleeding and enhance healing
- Innovative study to reduce AML treatment side effects
- PHD inhibitors offer hope for AML treatment
- New hope for hypertensive treatment for sickle cell
- April 2024 Message from BSH President - Dr Josh Wright
- Brain study may aid care of sickle cell pain crises
- Campaigners urge government to prioritise leukaemia research
- Trial results for gene therapy for sickle cell and thalassaemia published
- Thank you to Dr Josh Wright, BSH President, 2022-2024
- Coin-sized device could transform blood diagnostics
- Novel treatment developed for T-cell leukaemias and lymphomas
- Survivorship portal for paediatric cancer launched
- “Decisive step forward” in creation of universal donor blood
- Plan to improve myeloma diagnosis
- U-turn as NHS offers new sickle cell drug
- AML treatment assessed for over-80s
- New clonal haematopoiesis genes found
- Proposal for new immune checkpoint target
- BSH statement on the Infected Blood Inquiry
- BSH Crucible Prize: Interview with 2024 winner Dr Lisa Jeffers
- BSH Lifetime Achievement Award 2024
- Hope for “gentler” stem cell transplants
- Infected blood inquiry backs peer review and calls for extra patient voice
- Exercise may improve rituximab treatment for CLL
- Welcome to new President, Dr Sue Pavord
- May 2024 Message from BSH President - Dr Sue Pavord
- Ageing linked to “short cut” hyperreactive platelets
- Scientists find mutations underlying childhood immune disorders
- Possible tattoo link to lymphoma
- Challenge to reduce bleeding risk from low-dose direct oral anticoagulants
- Childhood AML tracked to foetal chromosomal changes
- Role of neutrophils in CAR-T complication studied
- New approach to reducing stem cell treatment distress
- Pseudo lymph node might improve CAR-T
- Lung microbiomes predict risk to child stem cell recipients
- Hopeful results from sickle gene editing
- Immune suppressant supercharges Hodgkin’s treatment
- Leukaemia T cells age centuries in one life-time
- June 2024 Message from BSH President - Dr Sue Pavord
- Charity raise alarm as myeloma combination faces loss of approval
- Ageing in HSCs linked to declining growth factor levels
- Testing for IgG reduces infection risk for blood cancer patients
- Gene-protein study points to opportunities to improve myeloma treatment
- Step forward for engineered plasma cell therapy
- Whole genome sequencing improving paediatric care in England
- Bacteriophage as GvHD treatment?
- Platelet discoveries point to immune role
- Tailored drug may combat drug-resistant AML
- Donor background affects stem cell transplant success
- Pregnancy hope after stem cell transplant
- Some blood cancer patients suffer from growing NHS delays
- NHS blood transfusion strategy development begins
- Hydroxyurea does not affect ovarian reserve in female SCD patients
- Blinatumomab improves MRD-negative ALL survival
- July 2024 Message from BSH President - Dr Sue Pavord
- Toxicity monitoring period for CAR-T could be reduced, study suggests
- Immune cell offers hope for preventing GvHD
- Iron metabolism offers target for improving AML care
- Discovery points to improving stem cell harvesting
- England approves beta-thalassaemia gene therapy
- New targets for preventing infant ALL drug resistance
- Macrophage ‘appetiser’ could improve immunotherapy
- Genetic variations may predict relapse risk in childhood ALL
- World’s men face increasing risk from blood cancers
- Genetic target for treatment of stress-induced blood disorders
- P-bodies offer hope for AML treatments
- UK project to find genetic profile of best cell donors
- August 2024 Message from BSH President - Dr Sue Pavord
- Hope for new treatment for infant leukaemia
- Low-intensity transplants may benefit sickle cell patient lungs
- Trial of drone transport for blood products
- Call to improve UK blood cancer survival
- HIV patient achieves remission by transplant without protective mutation
- Lab-developed blood stem cell success in Australia
- National Non-Hodgkin Lymphoma Audit (NNHLA) - State of the Nation Report published
- Risk of second cancers after CAR-T assessed
- Scotland gains two new myeloma treatments
- Sickle cell trait link to blood clots examined
- Bleeding risks studied in cancer patients
- New blood group solves half a century of mystery
- Pomalidomide successfully treats bleeding disorder
- September 2024 Message from BSH President - Dr Sue Pavord
- Genetic analysis points to low intensity treatments for some B-cell ALL patients
- NHS offers new oral drug for acute myeloid leukaemia
- Type 2 immune response may boost CAR-T
- The annual John Dacie Lecture at the 65th BSH Annual Scientific Meeting
- National Pathology Week Webinars 2024
- JAK inhibitor shows promise for CML
- Neonate screening begins for rare diseases
- Warning over sickle cell stroke risk
- Epigenetic finding may improve myeloma immunotherapy
- Multimillion dollar project to discover mysteries of the marrow
- Young women invited to be stem cell donors
- SHOT is pleased to announce the appointment of Dr Megan Rowley as the new Chair of the SHOT Steering Group
- Cancer survivors to help in AI study of immune response
- Improved humanised mice could boost immunotherapy research
- New CAR-T offers hope for T-ALL
- Welcome as myeloma antibody extended to benefit more patients
- October 2024 Message from BSH President - Dr Sue Pavord
- Features identified that might predict CAR-T success
- New concessions in England on myeloma treatment
- Stem cells studied decades after transplant
- AI on the way for bone marrow cell counts
- Multimillion-pound project to develop blood stem cell production
- NHS changes rules following interferon shortage
- NHS Fellowship in Clinical AI
- Chinese haematologists study COVID vaccine side effect
- Hope for Diamond-Blackfan gene therapy
- Myeloma microenvironment atlas unveiled
- Welcome to the new Editors of the British Journal of Haematology & eJHaem
- New role for glutamine in red blood cells discovered
- NSAIDs boost anticoagulant bleeding risk
- Tropical virus warning system introduced for UK blood supplies
- November 2024 Message from BSH President - Dr Sue Pavord
- CRISPR trial for sickle cell announced
- Impact of checkpoint inhibitors on immune system
- Innovative therapy developed for diffuse large B cell lymphoma
- Antibody shows promise as haemophilia treatment
- JAK inhibitor tested for graft v host disease
- Second generation CAR-T shows promise for ALL
- December 2024 Message from BSH President - Dr Sue Pavord
- Honours for haematologists
- Improved CAR-NK cell immunotherapy for AML
- Success for technique to test banked blood cells
- Backing for reduced dose oral anticoagulants
- Link between mutation and clonal haematopoiesis revealed
- New guidance on blood cancer during pregnancy
- Natural killer cell immunotherapy shows promise
- Novel breast cancer drug offers hope for myeloid cancers
- Persistent DNA damage offers clue to blood cancer causes
- Enter The Royal College of Pathologists’ Foundation Essay Prize
- Committee & SIG Highlights 2024
- Hepatitis B risk during immunosuppressive treatment
- Sickle cell impact on the brain studied
- ‘Sprinters’ and ‘marathon runners’ in CAR T treatment
- January 2025 Message from BSH President - Dr Sue Pavord
- Obituary – Professor Eric Preston (1935-2025)
- Developmental changes linked to lifetime cancer risk in mice
- How COVID boosters helped blood cancer patients
- UK approval for gene therapy for severe sickle cell disease
- Myeloma survivorship project under way
- Progress in asparaginase improvement
- Sickle cell trait should not be listed as a cause of death – ASH
- Case study of patient acquiring new cancer after transplant
- New blood clotting disorder described
- Myeloma ‘break-out’ lesions in the bone investigated
- Call for early genetic testing for myeloma patients
- New CAR-T approved for lymphoma in England
- Studies back anticoagulant treatment for elderly
- February 2025 Message from BSH President - Dr Sue Pavord
- Detailed study of lymphoma acquired from CAR-T therapy
- Major UK trial to test benefits of concentrated plasma for heart surgery complications
- Blinatumomab gains backing for MRD-negative ALL
- Researchers ready to test malaria drug for blood cancers
- Backing for efanesoctocog alfa in England for haemophilia
- UK-sourced plasma back in use in NHS
- New therapy is ALA CART for resistant disease
- NICE approves treatment for rare immune disorder
- X-SCID gene therapy tested in China
- One year on - a blog by BSH CEO Carol Bewick
- AI recognition of cell shape could revolutionise drug development
- Congenital heart disease link to childhood cancer
- Exportin-1 research could open way for new treatments
- blood donation for haemochromatosis
- BSH supports the Haematology Patients & Carers Congress (HPCC 2025)
- March 2025 Message from BSH President - Dr Sue Pavord
- New technique to improve adult stem cell harvest
- New candidates for sickle cell gene therapy identified
- Genetic benefits from frequent blood donation revealed
- NHS backing for late-stage Hodgkin’s treatment
- No need to pause BTKi for COVID vaccination
- Prothrombin concentrate found to improve surgical bleeding control
- Machine learning points to marker of CAR T failure
- New drive to develop freeze-dried synthetic blood
- Study investigates how menstrual cycle aggravates sickle cell pain
- April 2025 Message from BSH President - Dr Sue Pavord
- Myeloma drug resistance gene studied
- Grant to improve MGUS monitoring
- Hope for new AML combination treatment
- New Castleman’s subtype discovered
- New haemophilia treatment gains UK licence
- Statin linked to blood cancer survival
- Repeated bone marrow monitoring improves AML care
- Hope for lymphoma CAR-T treatment
- Machine learning finds alternatives to lymphoma chemotherapy
- Armoured CAR-T overcomes treatment resistant disease
- B-cell lymphoma prevalence set to increase
- Pre-conception screening for high-risk thalassaemia evaluated
- Apply for a Committee or SIG vacancy
- Membership Terms and Conditions
- Terms & Conditions
- Strategy 2024-26: Improving lives in the haematology community
-
Education
-
Conference and events
-
Events
- 2023 RCPath/IBMS Northern Symposium: Pathology and People
- Haematology for the Workforce of the Future (1)
- Paediatric Haematology Study Day 2022 (1)
- Educational webinar on the NHSBT Amber Alert - Weds 16 November 7pm
- FRCPath-2 Mock Revision Course
- Recent Advances in Haematology 2023
- 9th BSH Virtual CPD Talk
- 5th BSH Return to Work Day
- ISTH 2023 Congress
- BSH Paediatric SIG/PHTN Teaching Session January 2023
- BSH Paediatric SIG/PHTN Teaching Session March 2023
- ESH 6th International Conference: Acute Myeloid Leukemia “Molecular and Translational”: Advances in Biology and Treatment - #ESHAML2023
- ESH 7th Translational Research Conference: Lymphoid Malignancies - #ESHLYMPHOID2023
- 25th ESH iCMLf John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy - #ESHCML2023
- ESH 2nd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients - #ESHCART2023
- ESH 4th How to Diagnose and Treat Multiple Myeloma - #ESHMM2023
- ESH 3rd Translational Research Conference: Erythropoiesis Control and Ineffective Erythropoiesis - From Bench to Bedside - #ESHERYTHRO2023
- ESH 3rd How to Diagnose and Treat CML/MPN - #ESHCMLMPN2023
- UK CLL Forum Annual Scientific Day (4)
- UKMS Spring Day
- National ALL Update Day
- FRCPath Haemostasis and Thrombosis Training and Update Online Course (3)
- One Day Essentials: Haematology 2023
- An Introduction to Haematology Care (2)
- National Undergraduate Haematology Conference 2023: Broadening Perspectives
- Haematology in Obstetrics
- South West Lymphoma Group (1)
- ITP Update Day (4)
- BSBMTCT Scientific Day (4)
- Current Thinking in Haematological Malignancies (7)
- Haematological Malignancies Update Day (2)
- Current Thinking in Haematological Malignancies (8)
- 10th BSH Virtual CPD Talk
- 2023 Haematology Essentials
- 2023 Pitfalls in Haematology Diagnostics
- 20th National Annual Post ASH Update Educational Seminar
- 1st IPIG Conference: Recent Advances in Paroxysmal Nocturnal Haemoglobinuria; Haemolysis, Bone Marrow Failure & Thrombosis
- UK Forum on Haemoglobin Disorders - 55th Academic Meeting
- South West Myeloma Group (5)
- 2023 Haematology Clinical Science FRCPath Exam Preparation Study Half-Day
- 2023 ST3 Induction Day
- BioDriveAFS Investigators' Day
- 10th International Congress on Shwachman Diamond Syndrome (1)
- The HMDS Annual Haematology Update Day (2)
- South West Lymphoma Group (2)
- Transplant and Cell Therapy Updates for 2023
- 27th London Lymphoma Forum
- What's New in Haematological Malignancies (1)
- Haematology Highlights for the UK
- 4th ILROG Educational Conference: Radiotheraphy in Modern Management of Haematological Malignancies
- BSBMTCT Scientific Showcase: Advanced Cellular Therapy (2)
- FRCPath 1 Haematology Revision Course (2)
- CLL Study Day for Nurses
- 6th BSH Return to Work Day
- BSH Paediatric SIG/PHTN Teaching Session May 2023
- Haematological Malignancy Diagnostic Service (HMDS) Course
- South West Haemostasis and Thrombosis Meeting (3)
- REDRESS Study Launch Event
- Equitable partnerships and sharing learning
- Advances in Precision Oncology for Blood Cancers
- BSH Paediatric SIG/PHTN Teaching Session July 2023
- CAR-T Study Day for Nursing and Allied Healthcare Professionals
- 6th South West BMT Training Day
- 3rd North BMT Training Day
- South West Lymphoma Group (3)
- UK CLL Forum Clinical Sciences Day (4)
- Immunomodulation Update Day
- FRCPath Haemostasis and Thrombosis Training and Update Online Course
- 2023 BSH IMT Day London
- 2023 BSH IMT Day Newcastle
- Current Thinking in Haematological Malignancies - What's New for 2023
- UK EBMT Nurses and AHP Group (4)
- South West Myeloma Group (6)
- UKMS Autumn Day
- UK North Myeloma Forum (1)
- Myeloproliferative Neoplasms Advances Day 2023
- 28th London Lymphoma Forum
- Current Thinking in Haematological Malignancies (9)
- BGS Transfusion
- BSH Paediatric SIG/PHTN Teaching Session September 2023
- Joint OAA and BSH Meeting
- BSH Haematology Taster Day 2023
- BSH 2023 Lymphoma Special Interest Group Meeting - MDT Dilemmas
- ESH 3rd Translational Research Conference: Chronic Lymphocytic Leukaemia - #ESHCLL2024
- ESH 9th Translational Research Conference: Myelodysplastic Syndromes - #ESHMDS2024
- SpR Red Cell Training
- International Pathology Day 2023 - Virtual Conference
- 4th South West Acute Leukaemia Forum
- CLL Study Day for Nurses (1)
- UK Lymphoma Trials Group
- CAR-T Educational Sessions for BSBMTCT-ACT Trainees' subgroup
- BSHT Annual Scientific Meeting (1)
- Genotyping Programme Webinar
- BSH Paediatric SIG/PHTN Teaching Session November 2023
- Caring for the Critically Ill Haematology Patient
- BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course 2023
- FRCPath 1 Haematology Revision Course (3)
- Post ASH Significant Highlights (3)
- Post ASH Highlights for Scotland - What's New in Haematological Malignancies
- UoB HaemSoc - Clinical Haematology: The Essentials Lecture Series
- Post ISTH & ASH Headlines 2024
- UK Haemato-Oncology Clinical Studies Group Trials Update Meeting
- Spring 2024 UCLH FRCPath Part 2 Revision Course
- FRCPath Haemostasis and Thrombosis Training and Update Online Course (4)
- CAR-T Educational Sessions for BSBMTCT-ACT Trainees' Subgroup (1)
- Advanced Haemostasis and Thrombosis Course
- ALL Patient Pathway - UCLH CAR T Masterclass
- FRCPATH- 1 Exam Course
- Recent Advances in Haematology 2025, including ASH Highlights 2024
- Post ASH and What's New in Haematological Malignancies
- Haematological Malignancy Diagnostic Service (HMDS) Course (2)
- What's New in Haematological Malignancies (2)
- Post ISTH & ASH Headlines 2025
- South West Lymphoma Group (5)
- East Midlands Lymphoma Forum
- East Midlands Myeloid Update Day
- UK North Myeloma Forum (2)
- UK CLL Forum Annual Scientific Day (5)
- A CLL refresher with gems from ASH24 - A complete evening training course - Evening 3
- A CLL refresher with gems from ASH24 - A complete evening training course - Evening Two
- A CLL refresher with gems from ASH24 - A complete evening training course
- 9th BSH Return to Work Day
- New Pathways in Advanced SM
- BSH Paediatric SIG/PHTN Teaching Session May 2025
- ESH 5th Scientific Workshop: The Haematological Tumour Microenvironment and its Therapeutic Targeting - #ESHMICRO2025
- 22nd National Annual Post ASH Update Educational Seminar
- ESH 4th How to Diagnose and Treat CML/MPN - #ESHCMLMPN2025
- ESH 4th Translational Research Conference on Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia - #ESHERYTHRO2025
- ESH 5th How to Diagnose and Treat Multiple Myeloma - #ESHMM2025
- UK Myeloma Society Spring Day
- ITP and other Autoimmune Cytopenias
- Haematology in Obstetrics course 2025
- Molecular Diagnostics Boot Camp
- ESH 4th Translational Research Conference: Acute Lymphoblastic Leukaemia - #ESHALL2025
- Haematological Malignancy Diagnostic Service (HMDS) Course (3)
- King's College Hospital CAR-T Preceptorship, May 2025
- UK North Lymphoma Forum
- Scientist career development - what comes next?
- 10th Annual BSH Return to Work Day
- 2025 ST3 Induction Day
- Global SIG Virtual CPD talks Clinical assessment of bleeding disorders
- BSBMTCT Scientific Day (5)
- 31st London Lymphoma Forum
- UKFHD 59th Academic Meeting
- Haematology is Global; get involved
- Events
- Annual Scientific Meeting
- Promote your haematology event
- Event Terms and Conditions
- Crucible Prize
- Event FAQs
- BSH 2024 Lymphoma Special Interest Group - MDT Dilemmas
- 2023 BSH Lymphoma SIG Online Meeting: MDT Dilemmas
- 2023 BSH ASM: Lifestyle Medicine Recording
- 2023 BSH ASM: New Horizons Recording
- Haematology for the Workforce of the Future 2022
-
Events
- Lectures and Videos
- Demonstration Videos
-
Haematology images
- Bone Marrow Transplantation
-
General Haematology
- Atypical lymphocyte in primary HIV infection
- Trephine biopsy in malignant melanoma
- Bone marrow aspirate in malignant melanoma
- Platelet aggregates, blood film
- Oxalosis, trephine biopsy section
- Intra-pelvic haemorrhage following trephine biopsy: CT scan of pelvis
- Paroxysmal nocturnal haemoglobinuria associated with haemophagocytic syndrome
- Gelatinous transformation
- Jordans' anomaly
- Cobra like macrophage in visceral leishmaniasis
- Bacilli in blood film
- Bacilli in blood film in pseudomonas septicemia
- Multiple mitochondria in normal and tumour cells
- Congenital Pelger–Huët anomaly
- Oral haematoma
- Histoplasma in peripheral blood neutrophil
- Burkitt-like cytology in biphenotypic acute leukaemia
- Burkitt-like cytology in biphenotypic acute leukaemia (1)
- Extreme neutrophil vacuolisation in sepsis
- Striking monocyte vacuolisation in sepsis
- Toxic granulation and striking vacuolisation of neutrophils in sepsis
- Intramonocytic malarial pigment
- Histoplasmosis in bone marrow
- Mycobacterium avium intracellulare infection in a patient with AIDS
- Mycobacterium avium intracellulare (MAI) on routine H&E stain of a bone marrow section from a patient with AIDS
- Diagnosis of systemic lupus erythematosus by bone marrow cytology
- LE cells in incubated bone marrow
- SLE diagnosed from bone marrow
- Metastatic malignant melanoma in bone marrow, MGG stain
- Metastatic malignant melanoma in bone marrow trephine biopsy section, immunohistochemistry, APAAP technique, with hmb45
- Toxic Granuation and Döhle bodies in a patient with severe bacterial infection
- Bone marrow sarcoidosis in a patient with diffuse large B-cell lymphoma
- Visceral leishmaniasis (2)
- Visceral leishmaniasis (3)
- Letterer-Siwe disease (1)
- Letterer-Siwe disease (2)
- Letterer-Siwe disease (3)
- Letterer-Siwe disease (4)
- Alveolar rhabdomyosarcoma infiltrating the bone marrow
- Bone marrow aspirate in Niemann-Pick disease
- Leishmaniasis
- Haemophagocytosis in probable typhoid fever (1)
- Haemophagocytosis in probable typhoid fever (2)
- Haemophagocytosis in probable typhoid fever (3)
- Haemophagocytosis in probable typhoid fever
- Probable granuloma in typhoid fever (1)
- Probable granuloma in typhoid fever (2)
- Döhle bodies and toxic granulation
- Endothelial cells, low power
- Endothelial cells, high power
- Binucleated lymphocytes
- Cytoplasmic fragments mistaken for malaria parasites (1)
- Cytoplasmic fragments mistaken for malaria parasites (2)
- Cytoplasmic fragments mistaken for malaria parasites (3)
- Haemosiderin in a plasma cell, May-Grünwald-Giemsa stain
- Tuberculous granulomas in a trephine biopsy section, low power
- Tuberculous granulomas in a trephine biopsy section, low power (ii)
- Tuberculous granulomas in a trephine biopsy section, high power
- Toxic granulation and left shift induced by G-CSF
- Nuclear dysplasia and Döhle body formation induced by G-CSF
- Neutrophil vacuolation induced by G-CSF
- Multiple Döhle bodies and nuclear dysplasia induced by G-CSF
- Döhle body and vacuolation induced by G-CSF
- Left shift, toxic granulation, Döhle bodies and nuclear dysplasia induced by G-CSF
- Dysplastic neutrophil with ring-shaped nucleus following G-CSF therapy
- Alder-Reilly anomaly in a neutrophil
- Alder-Reilly anomaly in two neutrophils
- Gasser cell (lymphocyte with heavy granules)
- Monocyte with heavy granules and vacuoles as the result of a mucopolysaccharidosis
- Neutrophil showing Alder-Reilly anomaly
- Lymphocyte in mucopolysaccharidosis
- Monocyte in mucopolysaccharidosis
- Carcinoma cells infiltrating bone marrow with reactive fibrosis
- Carcinoma cells infiltrating bone marrow (2) with reactive fibrosis
- Carcinoma cells in an imprint from a trephine biopsy section, low power
- Carcinoma cells in an imprint from a trephine biopsy section, high power
- PAS-block positivity suspected from a Romonowsky-stained film
- Buffy coat film showing a clump of carcinoma cells
- Sea-blue histiocyte
- Sea-blue histiocytes
- Melanonychia striata secondary to hydroxycarbamide
- Chemotherapy-induced dysplasia
- Leishman-Donovan bodies in the bone marrow
- Leishmaniasis (1)
- Cohesive epithelioid macrophages in a bone marrow aspirate indicating the presence of granulomas (low power)
- Cohesive epithelioid macrophages in a bone marrow aspirate indicating the presence of granulomas (high power)
- Histology of bone marrow granuloma, H& E, low power
- Histology of bone marrow granuloma, H& E, high power
- Erythroid island
- A Mott cell
- Haemophagocytosis in the bone marrow aspirate of a young woman with coeliac disease
- Gaucher disease discovered during pregnancy
- Normal bone marrow film, Jenner-Giemsa with phosphate buffer at pH 6.6
- Infection-related haemophagocytic lymphohistiocytosis (HLH) in a HIV stage 4 patient with Mycobacterium tuberculosis infection
- Neuroblastoma with neuropil
- Emperipolesis in a patient with RAEB-2
- Dural biopsy in extranodal Rosai-Dorfman disease, which radiologically and histologically mimicked meningioma (H& E)
- Dural biopsy in extranodal Rosai-Dorfman disease, which radiologically and histologically mimicked meningioma (immunohistochemistry for S-100)
- Fragmentation haemolysis secondary to sepsis in a three-month-old female infant
- Plasmacytoid lymphocyte (Tϋrk cell)
- Congenital hip dislocation in Fanconi anaemia, X-ray
- Howell-Jolly body-like neutrophil inclusion (1)
- Howell-Jolly body-like neutrophil inclusion (2)
- Monocytes ‒ yes, but monotony ‒ never!
- Haemophagocytic lymphohistiocytosis
- Reactive myelofibrosis in metastatic tumour of unknown origin
- Reactive myelofibrosis (reticulin stain) in a metastatic tumour of unknown origin
- Plasmodium falciparum gametocyte (i)
- Plasmodium falciparum gametocyte (ii)
- Reactive haemophagocytosis in a bone marrow aspirate
- The stages of mitosis
- Haemoglobin H disease
- Bone marrow metastatic involvement by penile squamous cell carcinoma
- Crystal-storing histiocytosis associated with plasma cell myeloma
- Neutrophils changed appearance with a new heart
- LD bodies with marrow plasmacytosis
- Tadpole in the marrow
- Large granular lymphocyte, blood film
- Perls' stain showing iron in macrophages
- Erythroid island with central macrophage
- Reactive lymphocytes in infection by Brucella spp (Brucellosis, also called undulant fever, or Malta fever)
- Disseminated metastatic prostatic carcinoma in a young male (1)
- Histoplasma in peripheral blood and bone marrow
- Howell-Jolly body-like inclusions in reactive myelocytes and metamyelocytes
- Non-immune haemolytic anaemia in a severe burns patient
- Mycobacterium avium intracellulare on bone marrow trephine
- Cryptococcus neoformans: Cerebrospinal fluid (CSF) cytospin and bone marrow trephine
- Prostatic adenocarcinoma metastasis in bone marrow (H&E stain)
- Haemophagocytic lymphohistocytosis successfully treated with Anakinra therapy
- Immunobiology
-
Lymphoid Malignancy
- Simultaneous diagnosis of precursor B-cell acute lymphoblastic leukaemia and chronic lymphocytic leukaemia, high power
- Neurolymphomatosis
- Anaplastic large cell lymphoma lymphoma
- Multiple myeloma 2, giant cell
- Syncytial neoplastic cells in paediatric Hodgkin lymphoma
- Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, low power
- Hodgkin lymphoma in the bone marrow, trephine biopsy section, immunohistochemistry for CD30, low power
- Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, high power, 1
- Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, high power, 2
- Classical Reed-Sternberg cell in film of fine needle aspirate (Jenner-Giemsa stain)
- Lymph node biopsy in Hodgkin lymphoma
- Immunohistochemistry in Hodgkin's disease (Hodgkin lymphoma)
- Blood film of mantle cell lymphoma in evolution
- Paratrabecular infiltration in follicular lymphoma
- Diffuse large B-cell lymphoma
- Finger necrosis in cold agglutinin disease
- Type 1 cryoglobulinaemia in a patient with low grade non-Hodgkin lymphoma
- Rouleaux formation in lymphoplasmacytic lymphoma
- Splenic marginal zone lymphoma with peripheral blood lymphocyte clusters
- Diffuse large B-cell lymphoma in leukaemic phase
- Comparison of Ki67 positivity in mantle cell lymphoma (left) and in blastoid transformation (right)
- FDG-PET scan in cutaneous blastoid mantle cell lymphoma showing intense activity in a subcutaneous nodule
- Cold agglutinin in non-Hodgkin lymphoma
- Follicular lymphoma in leukaemic phase
- Marginal zone lymphoma of bone: MRI appearance
- Marginal zone lymphoma of bone: histology
- Marginal zone lymphoma of bone: immunohistochemistry
- PET/CT showing neurolymphomatosis as the presenting feature in a relapsed diffuse large B-cell lymphoma
- Bone marrow aspirate in primary diffuse large B-cell lymphoma of bone marrow (i)
- Bone marrow aspirate in primary bone marrow diffuse large B-cell lymphoma (ii)
- Hairy cell leukaemia
- Anaplastic large cell lymphoma, ALK-positive, in pleural fluid
- Ziehl-Neelsen (ZN) stain demonstrating acid-fast bacilli, identified as M. chelonae, which were the cause of vascular-catheter-related bacteraemia
- Anaplastic large T-cell lymphoma
- Primary cutaneous T-cell non-Hodgkin lymphoma on the shin completely healed following radiotherapy
- Skin infiltration in patient with adult T-cell leukaemia/lymphoma
- Primary cutaneous ALK-negative anaplastic large T-cell lymphoma
- Blood film in adult T-cell leukaemia/lymphoma
- Immunohistochemistry in subcutaneous panniculitis-like T-cell lymphoma
- Sézary cells
- Anaplastic large cell lymphoma overspill into peripheral blood
- Leukaemic phase of extranodal NK/T cell lymphoma of nasal type, peripheral blood film
- Anaplastic large cell lymphoma
- Peripheral blood in T-prolymphocytic leukaemia
- Hyperpigmentation and nodularity of skin in POEMS syndrome
- Circulating myeloma cell in a patient with refractory multiple myeloma
- Extramedullary myeloma
- Multiple myeloma cells in cerebrospinal fluid
- Extramedullary plasmacytoma of lung, haematoxylin and eosin
- Flaming plasma cell in IgA myeloma
- Pathological fracture of the proximal third of the shaft of the left humerus in multiple myeloma
- Cryoglobulinaemia
- CT scan of the pelvis in amyloidosis
- Plasmacytoma of the orbit in multiple myeloma, MRI scan (2)
- Plasmacytoma of orbit, histology following orbital biopsy: left, hematoxylin and eosin; right, immunohistochemistry for CD38
- Histology and immunohistochemistry of unusual skin lesions in multiple myeloma
- Bone marrow in multiple myeloma (1)
- Bone marrow in multiple myeloma (4): unusual cytoplasmic inclusions in myeloma cells
- Bone marrow in multiple myeloma (5): unusual cytoplasmic inclusions in myeloma cells
- Myeloma cells with crystals (i)
- Myeloma cells with crystals (ii)
- Myeloma cells with crystals (iii)
- Auer-rod like crystals in macrophages in myeloma (i)
- Auer rod-like crystals in macrophages in multiple myeloma (ii)
- Extramedullary plasmacytoma of the sphenoid sinus: T2 weighted MRI image
- Phagocytosis by myeloma cells
- Circulating plasma cells and rouleaux in plasma cell leukaemia
- Plasmablast in plasma cell leukaemia
- Auer-rod like inclusions in multiple myeloma
- Myeloma cells including a trinucleated cell containing Auer-rod-like inclusions
- Tissue biopsy section, multiple myeloma, haematoxylin and eosin
- Giant myeloma cells
- Giant binucleate myeloma cell
- Giant trinucleate myeloma cell
- Giant quadranucleate myeloma cell
- Neoplastic pleural effusion in refractory multiple myeloma
- Intracranial plasmacytoma causing bilateral sixth nerve palsy (1)
- Intracranial plasmacytoma causing bilateral sixth nerve palsy (2)
- Multinucleated tumour cell in multiple myeloma
- Multinucleated cell in multiple myeloma
- Multinucleated plasma cell in multiple myeloma
- Giant multinucleated tumour cells in multiple myeloma
- A giant multinucleated tumour cell in multiple myeloma
- Rouleaux formation and plasma cell - peripheral blood film of a patient with multiple myeloma
- Plasma cells in multiple myeloma - peripheral blood film
- Multiple myeloma 5, Dutcher body
- Multiple myeloma (1)
- Multiple myeloma (2)
- Multiple myeloma (3)
- Multiple myeloma (4)
- Multiple myeloma (5)
- Multiple Myeloma 1, Dutcher bodies
- Blood film in chronic lymphocytic leukaemia, mixed cell type
- CT scan showing a macronodular pattern of infiltration in chronic lymphocytic leukaemia
- CLL and metastatic tumour
- Aggressive NK cell leukaemia/lymphoma
- Aggressive NK cell lymphoma
- Flow cytometry in NK-lineage large granular lymphocytic leukaemia
- Trephine biopsy in Hodgkin's disease
- Bone marrow aspirate showing a Reed-Sternberg cell
- Foamy macrophages in ALL
- A typical basket-shaped smear cell in acute lymphoblastic leukaemia
- A small blast cell in the peripheral blood
- Symptomatic osteonecrosis of the knee in a patient with Hodgkin lymphoma
- Gross disfigurement secondary to extensive diffuse large B-cell lymphoma of the scalp
- Hyperhaploid multiple myeloma: very rare high-risk genetic subtype
- Intracardiac lymphoma on MRI imaging.
- Russell bodies in bone marrow of patient with lymphoplasmacytic lymphoma (1)
- Russell bodies in bone marrow of patient with lymphoplasmacytic lymphoma (2)
- Bi-nuclear lymphocyte
- AITL-RDD
- T-ALL relapsing as AML: the same but different
- Predominance of plasma cells
- CAR-T cells found in CSF
-
Myeloid Malignancy
- Transformation of essential thrombocythemia to pure erythroid leukaemia
- Chronic myelomonocytic leukaemia
- Imatinib-induced myelodysplasia: clues in a peripheral blood film
- Leukaemia cutis
- Chronic myeloid leukaemia in accelerated phase
- Chronic myeloid leukaemia in chronic phase
- Hypopyon in blast crisis of chronic myelogenous leukaemia
- CML - Hypolobated small megakaryocyte and a pseudo-Gaucher cell
- Promyelocyte with a loose bundle of Auer rods acute promyelocytic leukaemia
- The retina in acute myeloid leukaemia
- Cytoplasmic RNP and basic protein content of blasts in AML
- ATRA-induced scrotal ulcers
- Fluorescence in situ hybridisation with ABL and RUNX1 probes (red) and ETV6 and BCR probes (green)
- Peripheral blood film in AML with t(9;11)(p22;q23)
- Blastic plasmacytoid dendritic cell neoplasm, clinical photograph
- Blood film in acute megakaryoblastic leukaemia
- Blood film in acute megakaryoblastic leukaemia (1)
- Acute basophilic leukaemia, bone marrow aspirate
- Clinical features of haematodermic CD4+CD56+ neoplasm (blastic plasmacytoid dendritic cell neoplasm)
- Haemophagocytosis
- Acute megakaryoblastic leukaemia, peripheral blood
- Acute myeloid leukaemia, blood film
- AML with Pseudo-Chédiak-Higashi granules
- BM aspirate in acute promyelocytic leukaemia
- Auer rods
- PAS-positivity in acute erythroid leukaemia
- Acute leukaemia with histiocytic differentiation (1)
- Acute myeloid leukaemia with histiocytic differentiation (2)
- Acute myeloid leukaemia with histiocytic differentiation (3)
- Acute myeloid leukaemia with histocytic differentiation (4)
- Acute myeloid leukaemia in a patient with b thalassaemia major, post-splenectomy (1)
- Acute myeloid leukaemia in a patient with b thalassaemia major, post-splenectomy
- Auer rods in a neutrophil following ATRA treatment of acute promyelocytic leukaemia (i)
- Auer rod in a neutrophil in a patient with acute promyelocytic leukaemia treated with ATRA (ii)
- Dysplastic neutrophil during ATRA treatment of acute promyelocytic leukaemia (i)
- Dysplastic neutrophil during ATRA treatment of acute promyelocytic leukaemia (ii)
- Unusually large granules in M1 AML (i)
- Unusually large granules in M1 AML (ii)
- Unusually large granules in M1 AML (iii)
- Unusually large granules in M1 AML (iv)
- Unusually large granules in M1 AML (v)
- Unusually large granules in M1 AML (vi)
- Unusually large granules in M1 AML (vii)
- Unusually large granules in M1 AML (viii)
- Peripheral blood film in acute monoblastic leukaemia (Jenner-Giemsa stain)
- Bone marrow aspirate film in acute monoblastic leukaemia (Jenner-Giemsa stain)
- Non-specific esterase (NSE) in acute monoblastic leukaemia (substrate: alpha naphthyl acetate esterase)
- Extracellular Auer rods: Can this be another clue to a diagnosis of acute promyelocytic leukaemia?
- Acute monocytic leukaemia with leukaemic cells resembling histiocytes (i)
- Acute monocytic leukaemia with leukaemic cells resembling histiocytes (ii)
- Acute monocytic leukaemia with leukaemic cells resembling histiocytes (iii); note long cytoplasmic tails of some cells
- Acute monocytic leukaemia with leukaemic cells resembling histiocytes (iv); note that several cells have long cytoplasmic tails
- Mitotic figure in a leukaemic cell in a patient with acute monocytic leukaemia with leukaemic cells resembling histiocytes (v)
- Cytological/cytochemical diagnosis of the variant form of acute promyelocytic leukaemia
- Morphological diagnosis of variant form of acute promyelocytic leukaemia, MGG (i)
- Morphological diagnosis of variant form of acute promyelocytic leukaemia, MGG (ii)
- Sudan black B stain in the variant form of acute promyelocytic leukaemia, SBB (i)
- Sudan black B stain in the variant form of acute promyelocytic leukaemia, SBB (ii)
- Sweet syndrome
- Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing blast cells
- Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing an immature cell of basophil lineage
- Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing a nucleated red blood cell and a blast cell
- Dysplastic maturation during ATRA treatment of acute promyelocytic leukaemia
- Acute basophilic leukaemia, bone marrow, toluidine blue stain
- Acquired haemoglobin H disease
- Circulating dysplastic megakaryocyte in Down syndrome
- Hypolobulated megakaryocyte in 5q- syndrome
- Myelodysplastic syndrome, nuclear abnormalities
- Increased iron stores in refractory anaemia with excess of blasts
- Hypolobated megakaryocytes in refractory anaemia with excess of blasts
- Increased and dysplastic megakaryocytes in refractory anaemia with excess of blasts
- Dysplastic megakaryocytes, blast cells and increased proerythroblasts in RAEB
- A hypolobated megakaryocyte and immature cells, probably proerythroblasts, in a patient with RAEB
- Disorganised marrow in RAEB with increased immature cells, probably blast cells as well as proerythroblasts
- Myeloid neoplasm with FIP1L1-PDGFRA
- Intravascular haematopoiesis
- CT of chest showing extramedullary haemopoiesis
- Juvenile myelomonocytic leukaemia in beta thalassaemia major, low power of peripheral blood film
- Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (1)
- Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (2)
- Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (3)
- Splenic histology in a patient with advanced primary myelofibrosis
- Essential thrombocythaemia - giant megakaryocyte
- Systemic mastocytosis, bone marrow aspirate
- Emperipolesis
- Emperipolesis (1)
- PB, primary myelofibrosis
- Bone marrow trephine biopsy in primary myelofibrosis, low power
- Bone marrow biopsy - Parrafin embedded section - Masson trichrome stain - PRIMARY MYELOFIBROSIS showing collagen fibrosis & osteomyelosclerosis
- Neonatal Langerhans cell histiocytosis(LCH) showing reactive haemophagocytosis in the bone marrow aspirate
- MYC overexpressing acute myeloid leukaemia with botryoid white cell nuclei as well as unusual cytoplasmic inclusions
- Blastic plasmacytoid dendritic cell leukaemia
- Acute promyelocytic leukaemia (APML) like morphology in acute myeloid leukaemis (AML) with myelodysplastic syndrome (MDS) related changes
- Emperipolesis in megakaryocyte (1)
- Marrow collagen fibrosis (MT stain) (1)
- Marrow collagen fibrosis (VG stain) (1)
- AML with t(8;21)
- The Rods
- AML with myelodysplasia-related changes
- Faggot cells acute pro-myelocytic leukaemia
- Bone marrow necrosis in acute leukemia
- Therapy related AML with t(9;11) and KRAS mutation
- Myeloid blast cells
- Macrophage phagocytosis of atypical promyelocyte in acute promyelocytic leukemia.
- AML with MECOM rearrangement
- AML-pCT (post cytotoxic therapy) with megakaryoblast morphology
- AML with FLT3-ITD and NPM1 mutation
- Acute promyelocytic leukaemia (APML) variant presented with pulmonary embolism and pancytopenia
-
Paediatrics
- Blast cells in a neonate with Down's syndrome
- Leukaemic hypopyon
- A micromegakaryocyte in a child with refractory anaemia with excess of blasts-2 (RAEB2)
- Rhabdomyoblasts in the peripheral blood in rhabdomyosarcoma
- Hereditary xerocytosis, blood film
- ABO haemolytic disease of the newborn (HDN)
- Dystrophic nails in dyskeratosis congenita
- Osteopetrosis, trephine biopsy section
- Bilirubin crystals in neonatal hyperbilirubinaemia
-
Platelets and Haemostasis
- Scurvy
- Platelet satellitism
- Normal platelet EM
- Grey platelet syndrome EM
- Intraretinal haemorrhage in autoimmune thrombocytopenic purpura
- Submacular haemorrhage in autoimmune thrombocytopenic purpura
- Macular retinal atrophy following submacular haemorrhage in autoimmune thrombocytopenic purpura
- A cord-like fragment of megakaryocyte cytoplasm in the bone marrow of a patient with immune thrombocytopenia
- Cord-like fragments of megakaryocyte cytoplasm in the bone marrow of a patient with immune thrombocytopenia
- Haemarthroses
- Knee showing haemarthrosis
- Patient with acquired factor VIII deficiency
- Suspected Bernard-Soulier syndrome, 4
- Suspected Bernard-Soulier syndrome, 1
- Suspected Bernard-Soulier syndrome, 2
- Suspected Bernard-Soulier syndrome, 3
- Osler-Weber-Rendu disease
- Haemorrhagic diathesis in a bulimia nervosa patient
- Haemophilic pseudocyst
-
Red Cell Disorders
- Pyruvate kinase deficiency, post-splenectomy
- Erythroid islands: the crèches for the baby erythroids!
- An erythroid island
- Stomatocytes
- Sickle cell anaemia
- Coexisting sickle cell anaemia and G6PD deficiency
- Bone marrow fibrosis following bone marrow infarction in sickle cell anaemia
- Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film
- Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film, high power
- Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film, high power (1)
- Dyserythropoiesis in beta thalassaemia major
- Erythroid hyperplasia, basophilic stippling and two erythroblasts containing alpha chain inclusions in beta thalassaemia major
- Two alpha chain inclusions in an erythroblast in a patient with beta thalassaemia major
- Dyserythropoiesis and an erythroblast containing an alpha chain inclusion in beta thalassaemia major
- Hyperplastic erythropoiesis and a macrophage containing erythroblasts and cellular debris, a visual representation of ineffective erythropoiesis
- Iron-laden macrophage in beta thalassaemia major; there is cellular debris and refractile brown haemosiderin within the macrophage
- An erythroblast in beta thalassaemia major showing dyserythropoiesis (lobulated nucleus)
- An erythroblast in beta thalassaemia major showing a paranuclear alpha chain inclusion and dyserythropoiesis (lobulated nucleus)
- Two erythroblasts showing defective haemoglobinisation in beta thalassaemia major
- Ineffective erythropoiesis in beta thalassaemia major; a macrophage contains phagocytosed erythroblasts and golden-brown haemosiderin
- Haemoglobin H disease
- Dyserythropoiesis and Howell-Jolly bodies in defectively haemoglobinised cells. Normal transfused cells are also present
- Alpha chain inclusion in a circulating erythroblast
- Alpha chain inclusion surrounded by basophilic stippling in a circulating erythroblast
- Three erythroblasts containing alpha chain inclusions and small Howell-Jolly bodies
- Alpha chain inclusions, Howell-Jolly bodies and basophilic stippling
- Haemoglobin H inclusions
- Haemoglobin H inclusions (1)
- Acanthocytosis in abetalipoproteiaemia
- Dehydrated variant of hereditary stomatocytosis
- Haemoglobin H disease and G6PD deficiency (1)
- Haemoglobin H disease and G6PD deficiency (2)
- Haemoglobin H disease and G6PD deficiency (3)
- Pyruvate kinase deficiency, post-splenectomy (2)
- Pyruvate kinase deficiency, post-splenectomy (1)
- Coexistence of G6PD deficiency and sickle cell anaemia
- Combined vitamin B12 and folate deficiency
- Combined B12 and folate deficiency
- Marked hypochromia and microcytosis in severe iron deficiency anaemia
- A micronormoblast in the circulation in severe iron deficiency anaemia
- Elliptocytes (pencil cells) and marked hypochromia and microcytosis in severe iron deficiency anaemia
- Haemolytic uraemic syndrome, peripheral blood film
- Plasmodium malariae
- Malaria in a patient with Southeast Asian ovalocytosis
- Malaria in a patient with Southeast Asian ovalocytosis (1)
- Cabot's ring
- Microangiopathic haemolytic anaemia resulting from a viper bite
- Lantern cells after kidney transplant
- Lantern cells after kidney transplant 2
- Lantern cells after kidney transplant 3
- Asexual and sexual mature Plasmodium vivax sharing a red cell
- HbH-like inclusions in congenital sideroblastic anaemia
- Sickled red blood cells
- G6PD enzyme deficiency\/AIHA\/Favism
- Transfusion Medicine
- Students
- Submit content
-
Conference and events
-
Grants
- Annual Scientific Meeting Scholarships
- ASH-BSH Abstract Achievement Award
- Cohort Study Grant
- Early-Stage Research Start-up Grants
- Genomics Grant
- Global Haematology Scholarship
- Meeting Support
- Student Elective Scholarships
- Trainee Educational Bursaries
- Travel Scholarships
- Visiting Fellow
- Grants - our impact
- Grants FAQs
-
Guidelines
-
Guidelines
- Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies
- Diagnosis of B12 and Folate Deficiency
- Diagnostic Pathway for the Investigation of Thrombocytosis
- Investigation and Management of Adults and Children Presenting with Thrombocytosis
- Laboratory Diagnosis of Functional Iron Deficiency
- Management of Acute Chest Syndrome in Sickle Cell Disease
- Modification of Diagnostic Criteria for Essential Thrombocythaemia
- Use of Multicolour Flow Cytometry in the Diagnosis of Haematological Neoplasms
- Diagnosis and Management of Acquired Coagulation Factor Inhibitor
- Diagnosis and management of respiratory viral infections in patients with haematological malignancy
- Haematological Malignancies and ITU
- Investigation and Management of Mantle Cell Lymphoma
- Investigation and Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Management of AML in Pregnancy
- Management of Tumour Lysis Syndrome in Adults and Children with Haematological Malignancies
- Diagnosis and Management of Rare Coagulation Disorders
- Diagnosis and Management of Thrombocytopenic Purpura and Other Thrombotic Microangiopathies
- Diagnosis and Management of Von Willebrand Disease
- Diagnosis and Treatment of Factor VIII and IX Inhibitors in Congenital Haemophilia
- Investigation and Management of Venous Thrombosis at Unusual Sites
- Investigation, Management and Prevention of Venous Thrombosis in Children
- Management of Bleeding in Patients on Antithrombotic Agents
- Oral Anticoagulation with Warfarin - 4th Edition
- Patient Self-Testing and Self-Management of Oral Anti-Coagulants with Vitamin K Antagonists
- Travel-Related Venous Thrombosis
- Use of Vena Cava Filters
- Administration of Blood Components
- Clinical Use of Apheresis Procedures
- Pre-Transfusion Compatibility Procedures in Blood Transfusion Laboratories
- The Estimation of Fetomaternal Haemorrhage
- Transfusion for Fetuses, Neonates and Older Children
- Use of Anti-D immunoglobulin for the Prevention of Haemolytic Disease of the Fetus and Newborn
- Use of Platelet Transfusions
- Validation and Qualification, Including Change Control for Hospital Transfusion Laboratories
- Investigation and Management of Eosinophilia
- Diagnosis and Management of Primary Autoimmune Haemolytic Anaemia
- Management of Drug-Induced Immune and Secondary Autoimmune Haemolytic Anaemia
- Peri-Operative Management of Anticoagulation and Antiplatelet Therapy
- Red Cell Transfusion in Sickle Cell Disease Part I
- Red Cell Transfusion in Sickle Cell Disease Part II
- Diagnosis and Management of Disseminated Intravascular Coagulation
- Use of Imaging in the management of patients with myeloma
- Management of Thrombotic and Haemostatic issues in Paediatric Malignancy
- Spectrum of fresh frozen plasma and cryoprecipitate products
- Diagnosis and therapy of genetic haemochromatosis (review and 2017 update)
- Investigation and management of a raised serum ferritin
- Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease
- Investigation and management of Transient Leukaemia of Down Syndrome
- Good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma
- The use of viscoelastic haemostatic assays in the management of major bleeding
- Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma
- Diagnosis and management of polycythaemia vera
- Management of specific situations in polycythaemia vera and secondary erythrocytosis
- The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: Good Practice Paper
- The management of primary mediastinal B‐cell lymphoma: Good Practice Paper
- Point of Care in General Haematology
- UK guidelines on the management of iron deficiency in pregnancy
- Laboratory diagnosis of G6PD deficiency
- The use of prophylactic factor replacement for children and adults with Haemophilia A and B
- Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis
- Guideline on the investigation and management of follicular lymphoma
- Guideline on the diagnosis and management of chronic myeloid leukaemia
- Guidelines on the use of irradiated blood components
- Diagnosis and Management of Hereditary Spherocytosis
- Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V)
- Guidelines on the diagnosis, investigation and initial treatment of myeloma
- Guideline on Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients
- Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes
- Guidelines for the management of adult myelodysplastic syndromes
- Guidelines for the Management of sickle cell disease in pregnancy
- The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelod-ysplastic neoplasms, and related disorders
- GPP Management of cardiovascular complications of bruton tyrosine kinase inhibitors
- GPP Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients
- Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias
- The management of Castleman disease
- GPP Richter transformation of chronic lymphocytic leukaemia
- Good Practice Paper for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children
- Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)
- Guidelines on the diagnosis and management of Waldenström macroglobulinaemia
- Guideline for the first-line management of Classical Hodgkin Lymphoma
- Guidelines for the laboratory diagnosis of malaria
- Guideline for the treatment of chronic lymphocytic leukaemia
- The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
- Guidelines for thrombophilia testing
- Haematological management of major haemorrhage
- Haematological evaluation of bruising and bleeding in children undergoing child protection investigation for possible physical maltreatment
- Management of older patients with frailty and acute myeloid leukaemia: A British Society for Haematology good practice paper
- Recommendations for laboratory testing of UK patients with acute myeloid leukaemia: A British Society for Haematology good practice paper
- Management of secondary central nervous system lymphoma: A British Society for Haematology Good Practice Paper
- Joint guidance from the British Societies of Interventional Radiology and Haematology on managing Bleeding Risk during Procedures in Interventional Radiology
- Guidelines for screening and management of late and long-term consequences of myeloma and its treatment
- British Society for Haematology guideline for anticoagulant management of pregnant individuals with mechanical heart valves
- Significant haemoglobinopathies: A guideline for screening and diagnosis
- Guideline on the investigation and management of acute transfusion reactions
- Investigation and management of monoclonal gammopathy of undermined significance
- Diagnosis and management of mantle cell lymphoma
- Diagnosis and evaluation of prognosis of myelofibrosis
- Diagnosis and management of marginal zone lymphomas
- The management of myelofibrosis: A British Society for Haematology Guideline
- Diagnosis and management of heparin-induced thrombocytopenia: Third edition
- The management of newly diagnosed large B-cell lymphoma
- Guidelines for the diagnosis and management of adult aplastic anaemia
- Guidelines for the specification, implementation and management of IT systems in hospital transfusion laboratories
- Diagnosis and management of smouldering myeloma
- The assessment and management of bleeding risk prior to invasive procedures
- Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology
- Prevention and treatment of infection in patients with an absent or hypofunctional spleen
- Guideline on the use of predeposit autologous donation
- Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes
- Cancer-associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline
- Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update
- Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients
- Prevention and management of indwelling catheter-related thrombosis in sickle cell disease and thalassaemia
- Guidelines on the investigation and management of antiphospholipid syndrome
- Central nervous system prophylaxis in large B-cell lymphoma: A British Society for Haematology Good Practice Paper
- Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline
- Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
- Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma GPP
- Diagnosis and management of monoclonal gammopathy of renal significance
- BSH position paper on European Society of Intensive Care Medicine (ESICM) guideline: ‘Transfusion strategies in non-bleeding critically ill adults’
- Guideline for the investigation and management of red cell antibodies in pregnancy
- About our Guidelines
- Proposing and writing a new BSH Guideline
- For Guidelines writers and Taskforce Members
- Archived Guidelines
- Guidelines Listing Plain Text
- Audio & written commentary
- ASM Guidelines Videos
-
Guidelines
- Membership
-
BSH at 60
- Haematology timeline
-
60 at 60 Exhibition
- ‘All agreed’: Discover the story of the Society’s earliest days in 1960
- Tools of the trade
- Reflections on the pandemic
- 60 at 60 contributions
- Share your reflections
- Signposting history
- Snakes alive! How the Reptile House at London Zoo started a thirty-year medical mystery
- BSH Past Presidents
- Multidisciplinary Haematology Team
- Building a Community
- Overcoming Obstacles
- Inspiring Others
- Enhancing Care
- Pioneering Research
- BSH 2020 Gallery
- Acknowledgements
- Advocacy
- Processing Notice
- Privacy Policy
- Sitemap
- Profile
- Sign Up
- Login
- Login Success
- Website Registration Required
- Register Success
- Forgot Password
- Reset Password
- Membership wizard
- Membership Payment Confirmation
- Membership Payment Failed
- Membership Signup Confirmation
- Proposer Verification Confirmation
- Member Submission Failed
- Member Renewal
- Subscription Renewal complete
- Subscription Renewal Failed
- BSH Member access only
- Full member access only
- Committee or SIG application submitted
- SIG Member access only
- PHTN Member access only
- My BSH
- Website Signup
- Event Signup
- Event Payment Confirmation
- Event Payment Failed
- Event Booking Failed
- Event delegate access only
- Video Access Payment Failed
- Image submission
- Grant submission confirmation
- Guidelines Declaration of Interest Form submission confirmation
- Sounding Board sign up
- Sounding Board feedback submitted
- BSH Guidelines podcast feedback submitted
- error
- Access not permitted
- Access temporarily unavailable
-
About Us
